Growing evidence that healthcare research should not be entrusted to Big Pharma:
In the last decade, the average cost of a brand-name cancer drug jumped from about $5,000 per month to $10,000 per month in 2013, according to a new IMS Institute for Healthcare Informatics study out this morning. Oncology, by far, remains the largest area of focus in drug research and development, IMS said.
If they found a potential low-cost cure, would they be tempted to kill the research? Youbetcha.
Read more at Expensive cancer drugs are all the rage in pharma these days.